Cite
HARVARD Citation
Angelico, F. et al. (2021). Assessment of hepatic fibrosis in MAFLD: A new player in the evaluation of residual cardiovascular risk?. Digestive and liver disease. 53 (3), pp. 383-384. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Angelico, F. et al. (2021). Assessment of hepatic fibrosis in MAFLD: A new player in the evaluation of residual cardiovascular risk?. Digestive and liver disease. 53 (3), pp. 383-384. [Online].